These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12615293)

  • 21. Statins and stroke prevention.
    Paciaroni M; Bogousslavsky J
    Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1231-43. PubMed ID: 19814666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing lipid management in patients with acute coronary syndromes.
    Pepine CJ
    Am J Cardiol; 2003 Feb; 91(4A):30B-35B. PubMed ID: 12615296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment with statins: lowering of cholesterol or more?].
    Rutishauser J
    Praxis (Bern 1994); 2006 Jan; 95(4):107-10. PubMed ID: 16485605
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness of statins in acute coronary syndromes.
    Foody JM; Nissen SE
    Am J Cardiol; 2001 Aug; 88(4A):31F-5F. PubMed ID: 11520485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Unstable atheromatous plaque. Physiopathology and therapeutic approach to coronary insufficiency].
    Berkenboom G
    Rev Med Brux; 2001 Dec; 22(6):497-502. PubMed ID: 11811045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging inflammatory markers for assessing coronary heart disease risk.
    Corson MA
    Curr Cardiol Rep; 2009 Nov; 11(6):452-9. PubMed ID: 19863870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins in acute coronary syndromes: the sooner, the better?
    Schwartz GG
    Am Heart J; 2005 Mar; 149(3):377-80. PubMed ID: 15864223
    [No Abstract]   [Full Text] [Related]  

  • 29. [LDL cholesterol in cardiovascular risk patients should be as low as possible].
    MMW Fortschr Med; 2007 Oct; 149(41):44-5. PubMed ID: 17992793
    [No Abstract]   [Full Text] [Related]  

  • 30. Benefits of the statins: beyond cholesterol.
    Harv Mens Health Watch; 2001 Aug; 6(1):1-5. PubMed ID: 11546633
    [No Abstract]   [Full Text] [Related]  

  • 31. The use over time of statins in coronary patients in an Italian tertiary referral center.
    Gaspardone A; Proietti I; Altamura L; Tomai F; Versaci F; Crea F; Chiariello L; Gioffrè PA
    Ital Heart J; 2001 Nov; 2(11):848-53. PubMed ID: 11770871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional evaluation of lipid-lowering therapy by pravastatin.
    Schoebel FC; Jax TW; Strauer BE; Leschke M
    Circulation; 1998 May; 97(18):1874-5. PubMed ID: 9603548
    [No Abstract]   [Full Text] [Related]  

  • 33. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study.
    Macin SM; Perna ER; Farías EF; Franciosi V; Cialzeta JR; Brizuela M; Medina F; Tajer C; Doval H; Badaracco R
    Am Heart J; 2005 Mar; 149(3):451-7. PubMed ID: 15864233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins: potent vascular anti-inflammatory agents.
    Liao JK
    Int J Clin Pract Suppl; 2004 Oct; (143):41-8. PubMed ID: 16035395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiatherosclerotic effects of statins: LDL versus non-LDL effects.
    Selwyn AP
    Curr Atheroscler Rep; 2007 Oct; 9(4):281-5. PubMed ID: 18173955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005
    [No Abstract]   [Full Text] [Related]  

  • 37. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
    Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
    N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease.
    Undas A; Brozek J; Musial J
    Clin Lab; 2002; 48(5-6):287-96. PubMed ID: 12071579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.